UKE study: No effects eight months after cannabis illegalisation
Researchers at the University Medical Center Hamburg-Eppendorf have investigated the short-term effects of cannabis illegalization for adults in Germany. The result: There were no significant changes compared to the time before the change in the law. It was based on data from a population survey in Germany and Austria before and after the illegalization. In Austria, the possession of cannabis remains prohibited.
In Germany, cannabis use among 18- to 64-year-olds rose from 12.1 to 14.4 percent. The increase was comparable to Austria. Among monthly users, slightly fewer people drove under the influence of cannabis in Germany than before legalisation and before a new THC limit was set in the blood. Here, too, there was no significant difference to Austria.
In 22 percent of the journeys under the influence of cannabis, alcohol or other substances were also consumed. Such mixed consumption trips decreased among weekly consumers. Driving alone under the influence of cannabis was most common among daily users.
Germany partially legalized the cultivation and possession of cannabis for adults in April 2024. In August 2024, a THC limit of 3.5 nanograms per milliliter of blood serum was set for road traffic. The results were published in The Lancet Regional Health – Europe.
Original Paper:
Editor: X-Press Journalistenbüro GbR
Gender Notice. The personal designations used in this text always refer equally to female, male and diverse persons. Double/triple naming and gendered designations are used for better readability. ected.
Most read
Innovative substance against periodontitis specifically blocks harmful bacteria Fraunhofer researchers have developed a substance that inhibits harmful bacteria in periodontitis wi...- “Erstmals verbinden wir damit zwei Einrichtungen über eine Strecke von mehr als 1.600 Metern – quasi ein Weltrekord†Das Universitätsklinikum Ulm hat ein Transportsystem für Laborproben implementiert, das die Labormed...
- New metabolic BMI enables more accurate risk assessment for metabolic diseases Researchers at the Universities of Leipzig and Gothenburg have developed an AI-based computational m...
